Head-to-head · Value Score
bmiMD vs Remedy Meds
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Remedy Meds a 55. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameRemedy Meds
#378 · Grade C · Watch List
Est. first month
From $299/mo (starting dose, compounded)
Save ~78% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 55 — an est. $99/mo first month, with no teaser step-up baked in. Remedy Meds isn't out of it: Shoppers who want mainstream telehealth GLP-1 access.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Remedy Meds |
|---|---|---|
| Value Score | 89 (A) | 55 (C) |
| Est. first month | $99/mo | From $299/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~78% |
| Semaglutide | $99/mo | From $299/mo (starting dose, compounded) |
| Tirzepatide | $139/mo | From $399/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Remedy Meds
Telehealth provider offering compounded semaglutide and tirzepatide programs.
Why it's a deal
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
The fine print
- Limited public information on program details
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Remedy Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.